HOOKIPA Pharma Inc.

Informe acción NasdaqCM:HOOK

Capitalización de mercado: US$27.5m

Salud financiera de hoja de balance de HOOKIPA Pharma

Salud financiera controles de criterios 4/6

HOOKIPA Pharma tiene un patrimonio de los accionistas total de $71.8M y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $109.7M y $37.9M respectivamente.

Información clave

0%

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$59.75m
PatrimonioUS$71.80m
Total pasivoUS$37.93m
Activos totalesUS$109.73m

Actualizaciones recientes sobre salud financiera

Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky

Nov 19
Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky

Is HOOKIPA Pharma (NASDAQ:HOOK) A Risky Investment?

Apr 26
Is HOOKIPA Pharma (NASDAQ:HOOK) A Risky Investment?

Recent updates

Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky

Nov 19
Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky

HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) 26% Dip In Price Shows Sentiment Is Matching Revenues

Sep 27
HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) 26% Dip In Price Shows Sentiment Is Matching Revenues

The Market Doesn't Like What It Sees From HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) Revenues Yet As Shares Tumble 29%

Aug 13
The Market Doesn't Like What It Sees From HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) Revenues Yet As Shares Tumble 29%

Why Investors Shouldn't Be Surprised By HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) 34% Share Price Plunge

Jun 22
Why Investors Shouldn't Be Surprised By HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) 34% Share Price Plunge

HOOKIPA Pharma Inc. (NASDAQ:HOOK) Shares Fly 25% But Investors Aren't Buying For Growth

Apr 28
HOOKIPA Pharma Inc. (NASDAQ:HOOK) Shares Fly 25% But Investors Aren't Buying For Growth

Analysts Just Made A Major Revision To Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenue Forecasts

Mar 24
Analysts Just Made A Major Revision To Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenue Forecasts

Need To Know: The Consensus Just Cut Its HOOKIPA Pharma Inc. (NASDAQ:HOOK) Estimates For 2023

Aug 11
Need To Know: The Consensus Just Cut Its HOOKIPA Pharma Inc. (NASDAQ:HOOK) Estimates For 2023

HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Just Slashed This Year's Revenue Estimates By 17%

May 16
HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Just Slashed This Year's Revenue Estimates By 17%

Is HOOKIPA Pharma (NASDAQ:HOOK) A Risky Investment?

Apr 26
Is HOOKIPA Pharma (NASDAQ:HOOK) A Risky Investment?

Need To Know: Analysts Are Much More Bullish On HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenues

Nov 19
Need To Know: Analysts Are Much More Bullish On HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenues

HOOKIPA wins FDA nod to start clinical studies for prostate cancer therapy

Jul 25

Newsflash: HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Have Been Trimming Their Revenue Forecasts

May 18
Newsflash: HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Have Been Trimming Their Revenue Forecasts

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($93.2M) de HOOK superan a sus pasivos a corto plazo ($28.6M).

Pasivo a largo plazo: Los activos a corto plazo de HOOK ($93.2M) superan a sus pasivos a largo plazo ($9.4M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: HOOK está libre de deudas.

Reducción de la deuda: HOOK no tiene deuda en comparación con hace 5 años, cuando su ratio deuda-patrimonio era de 3.8%.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: HOOK tiene menos de un año de cash runway basado en su flujo de caja libre actual.

Pronóstico de cash runway: HOOK tiene menos de un año de cash runway si el flujo de caja libre sigue reduciéndose a tasas históricas de 11.3% cada año


Descubre empresas con salud financiera